国外片剂工艺规程中英文对照 (模版)
阿司匹林片(片剂)工艺规程
阿司匹林片工艺规程1.产品名称及剂型产品名称：阿司匹林片产品剂型：片剂2.产品概述产品名称阿司匹林片汉语拼音名：Asipilin Pian英文名：Aspirin Tablets结构式：阿司匹林本品为２－（乙酰氧基）苯甲酸分子式：C9H8O4 分子量：本品含阿司匹林（C9H8O4）应为标示量的%%产品特点2.2.1性状本品为白色片2.2.2规格0.5g。
2.2.3类别解热镇痛非甾体抗炎药，抗血小板聚集药。
2.2.4用法与用量口服。
成人一次1片，若发热或疼痛持续不缓解，可间隔4-一6个小时重复用药一次。
24小时内不超过4片。
儿童用量请咨询医师或药师。
2.2.5贮藏密封，在干燥处保存。
2.2.6有效期3年。
3.处方和依据批投料处方阿司匹林60kg淀粉5kg枸橼酸滑石粉制成 12万片依据 执行标准：《中国药典》2010年版二部制法 取阿司匹林、淀粉和枸橼酸置高效湿法制粒机中混合均匀，用淀粉浆制粒；干燥；压片；瓶内包装及外包装，制得。
4. 工艺流程图物料工序检验入库中间站注：虚线框内为十万级洁净区。
5.操作过程及工艺条件备料5.1.1领料从库房领取合格原辅料，送入车间称量暂存间。
5.1.2粉碎过筛将以下物料依次粉碎过筛，过筛后再次称量，计算物料平衡，并严格复核。
制粒5.2.1配浆称取纯化水1kg置配浆锅中，加入1kg淀粉，搅拌使均匀，在搅拌下冲入10kg 纯化水加热至糊化，配成10%的淀粉浆作为粘合剂。
5.2.2制粒将60kg阿司匹林粉、4kg淀粉和0.6kg枸橼酸粉投入高速制粒机中，干混4分钟后，加入上述淀粉浆混合5分钟，开机制粒。
5.2.3干燥将上述湿颗粒吸入沸腾制粒机中，将设定好工艺参数（进风温度120±5℃，温度75±5℃，进风温度30±5℃）的冷空气通过初效中高效过滤器进适入后部加热室，经过加热器加热至进风所需温度后进入物料室，在引风拉动下物料呈流化态干燥45分钟至水份为3-4%时，停机出料。
制药工艺流程 英文
制药工艺流程英文《Pharmaceutical Production Process》Pharmaceutical production process, also known as pharmaceutical manufacturing, involves a series of steps and activities to produce a final pharmaceutical product that meets the required quality standards and regulatory requirements. The process begins with the discovery of a new drug molecule or the identification of a potential drug candidate. Once a drug candidate is selected, the pharmaceutical production process begins.The first step in the pharmaceutical production process is the development of the drug formulation. This involves the creation of a stable and effective dosage form for the drug, such as a tablet, capsule, or liquid solution. Formulation development also includes the selection of excipients, which are the inactive ingredients that are used to create the final dosage form.Once the drug formulation is developed, the next step is to manufacture the drug product. This involves the actual production of the dosage form in a pharmaceutical manufacturing facility. The manufacturing process may include activities such as mixing, granulation, compression, coating, and packaging.After the drug product is manufactured, it undergoes a series of quality control tests to ensure that it meets the required quality standards. These tests may include checks for assay, impurities, dissolution, and microbiological contamination. Once the drug product passes all quality control tests, it is ready for distribution and sale to patients.Throughout the pharmaceutical production process, regulatory requirements and good manufacturing practices (GMP) must be followed to ensure that the drug product is safe, effective, and of high quality. This includes maintaining a clean and sanitary manufacturing environment, conducting regular equipment and facility maintenance, and keeping detailed documentation of all production activities.In conclusion, the pharmaceutical production process is a complex and highly regulated series of steps that are essential for the production of safe and effective drug products. From drug formulation development to manufacturing and quality control testing, each step plays a crucial role in ensuring that the final drug product meets the required quality standards and regulatory requirements.。
制药工程专业英语第11单元课文中英文对照
PART 3 INDUSTRIAL PHARMACYUnit 11 Tablets (The Pharmaceutical Tablets Dosage Form)Role in TherapyThe oral route of drug administration is the most important method of administering drugs for systemic effects. Except in cases of Insulin therapy，the parenteral route is not routinely used for self-administration of medications. The topical route of administration has only recently been employed to deliver drugs to the body for systemic effects，with two classes of marketed products: Nitroglycerin硝酸甘油酯for the treatment of angina心绞痛and scopolamine莨菪胺for the treatment of motion sickness晕动病，指晕车、晕船等. Other drugs are certain to follow，but the topical route of administration is limited in its ability to allow effective drug absorption for systemic drug action. The parenteral route of administration is important in treating medical emergencies in which a subject is comatose昏迷的or cannot swallow，and in providing various types of maintenance therapy for hospitalized patients. Nevertheless，it is probable that at least 90 % of all drugs used to produce systemic effects are administered投药，给药by the oral route. When a new drug is discovered，one of the first questions a pharmaceutical company asks is whether or not drug can be effectively administered for its intended effect by the oral route. If it cannot，the drug is primarily relegated to被降级到administration in a hospital setting or physician's office. If patient self- administration cannot be achieved，the sales of the drug constitute only a small fraction of what the market would be otherwise. Of drugs that are administered orally，solid oral dosage forms represent the preferred class of product. The reasons for this preference are as follows. Tablets and capsules represent unit dosage forms in which one usual dose of the drug has been accurately placed. By comparison相比之下，liquid oral dosage forms，such as syrups，suspensions，emulsions，solutions，and elixirs，are usually designed to contain one dose of medication in 5 to 30 ml. The patient is then asked to measure his or her own medication using a teaspoon，第三部分工业药剂学第11单元药片(医药的片剂剂型)在治疗中的作用口服给药途径是通过给药获得全身作用效果中最重要的方法。
FDA-GMP中英文对照标准版
DIRECTION OF GMP (GOOD MANUFACTURING PRACTICE )OF RAW MATERIALS BY FDATable of Contents 目录1. INTRODUCTION1.1 Objective 目的1.2 Regulatory Applicability法规的适用性1.3 Scope 范围2. QUALITY MANAGEMENT .质量管理2.1 Principles 总则2.2 Responsibilities of the Quality Unit(s) 质量部门的责任2.3 Responsibility for Production Activities 生产作业的职责2.4 Internal Audits (Self Inspection) 内部审计（自检）2.5 Product Quality Review 产品质量审核3. PERSONNEL 人员3.1 Personnel Qualifications 人员的资质3.2 Personnel Hygiene 人员卫生3.3 Consultants 顾问4. BUILDINGS AND FACILITIES 建筑和设施4.1 Design and Construction 设计和结构4.2 Utilities 公用设施4.3 Water 水4.4 Containment 限制4.5 Lighting 照明4.6 Sewage and Refuse 排污和垃圾4.7 Sanitation and Maintenance 卫生和保养5. PROCESS EQUIPMENT 工艺设备5.1 Design and Construction 设计和结构5.2 Equipment Maintenance and Cleaning 设备保养和清洁5.3 Calibration. 校验5.4 Computerized Systems 计算机控制系统6. DOCUMENTATION AND RECORDS 文件和记录6.1 Documentation System and Specifications 文件系统和质量标准6.2 Equipment cleaning and Use Record 设备的清洁和使用记录6.3 Records of Raw Materials, Intermediates, API Labeling and Packaging Materials原料、中间体、原料药的标签和包装材料的记录6.4 Master Production Instructions (Master Production and Control Records)生产工艺规程（主生产和控制记录）6.5 Batch Production Records (Batch Production and Control Records)批生产记录（批生产和控制记录）6.6 Laboratory Control Records 实验室控制记录6.7 Batch Production Record Review 批生产记录审核7. MATERIALS MANAGEMENT 物料管理7.1 General Controls 控制通则7.2 Receipt and Quarantine 接收和待验7.3 Sampling and Testing of Incoming Production Materials 进厂物料的取样与测试7.4 Storage 储存7.5 Re-evaluation 复验8. PRODUCTION AND IN-PROCESS CONTROLS 生产和过程控制8.1 Production Operations 生产操作8.2 Time Limits 时限8.3 In-process Sampling and Controls 工序取样和控制8.4 Blending Batches of Intermediates or APIs 中间体或原料药的混批8.5 Contamination Control 污染控制9. PACKAGING AND IDENTIFICATION LABELING OF APIs AND INTERMEDIATES原料药和中间体的包装和贴签9.1 General 总则9.2 Packaging Materials 包装材料9.3 Label Issuance and Control 标签发放与控制9.4 Packaging and Labeling Operations 包装和贴签操作10. STORAGE AND DISTRIBUTION.储存和分发10.1 Warehousing Procedures 入库程序10.2 Distribution Procedures 分发程序11. LABORATORY CONTROLS 实验室控制11.1 General Controls 控制通则11.2 Testing of Intermediates and APIs 中间体和原料药的测试11.3 Validation of Analytical Procedures 分析方法的验证11.4 Certificates of Analysis分析报告单11.5 Stability Monitoring of APIs 原料药的稳定性监测11.6 Expiry and Retest Dating 有效期和复验期11.7 Reserve/Retention Samples 留样12. VALIDATION .验证12.1 Validation Policy 验证方针12.2 Validation Documentation 验证文件12.3 Qualification 确认12.4 Approaches to Process Validation 工艺验证的方法12.5 Process Validation Program 工艺验证的程序12.6 Periodic Review of Validated Systems 验证系统的定期审核12.7 Cleaning Validation 清洗验证12.8 Validation of Analytical Methods 分析方法的验证13. CHANGE CONTROL 变更的控制14. REJECTION AND RE-USE OF MATERIALS.拒收和物料的再利用14.1 Rejection 拒收14.2 Reprocessing 返工14.3 Reworking 重新加工14.4 Recovery of Materials and Solvents 物料与溶剂的回收14.5 Returns 退货15. COMPLAINTS AND RECALLS 投诉与召回16. CONTRACT MANUFACTURERS (INCLUDING LABORATORIES)协议生产商（包括实验室）17. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS 代理商、经纪人、贸易商、经销商、重新包装者和重新贴签者17.1 Applicability 适用性17.2 Traceability of Distributed APIs and Intermediates已分发的原料药和中间体的可追溯性17.3 Quality Management 质量管理17.4 Repackaging, Relabeling, and Holding of APIs and Intermediates原料药和中间体的重新包装、重新贴签和待检17.5 Stability 稳定性17.6 Transfer of Information 信息的传达17.7 Handling of Complaints and Recalls 投诉和召回的处理17.8 Handling of Returns 退货的处理18. Specific Guidance for APIs Manufactured by Cell Culture/Fermentation用细胞繁殖/发酵生产的原料药的特殊指南18.1 General 总则18.2 Cell Bank Maintenance and Record Keeping 细胞库的维护和记录的保存18.3 Cell Culture/Fermentation 细胞繁殖/发酵18.4 Harvesting, Isolation and Purification 收取、分离和精制18.5 Viral Removal/Inactivation steps 病毒的去除/灭活步骤19. APIs for Use in Clinical Trials 用于临床研究的原料药19.1 General 总则19.2 Quality 质量19.3 Equipment and Facilities设备和设施19.4 Control of Raw Materials 原料的控制19.5 Production 生产19.6 Validation 验证19.7 Changes 变更19.8 Laboratory Controls 实验室控制19.9 Documentation 文件20. Glossary 术语1. INTRODUCTION 1. 简介1.1 Objective 1.1目的This document is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality. It is also intended to help ensure that APIs meet the quality and purity characteristics that they purport, or are represented, to possess.本文件旨在为在合适的质量管理体系下制造活性药用成分（以下称原料药）提供有关优良药品生产管理规范（GMP）提供指南。
美国良好操作规范(GMP—CFRPart,参考译文)
美国良好操作规范（GMP—21CFR Part 110，参考译文）A分部—总则110.3 定义联邦食品、药物及化妆品条例（以下简称条例）第201节中术语的定义和解释适用于本部分的同类术语。
下列定义亦同样适用：1．酸性食品或酸化食品：是指平衡pH值为4.6或低于4.6的食品。
2．适当的：指为达到良好的公共卫生规范的预期目的所需要满足的要求。
3．面糊：是指一种半流体物质，通常包含面粉和其他辅料，食品的主要成分可浸在其中，或用它涂膜，或直接用来形成烘烤的食品。
4．热烫：除坚果和花生外，指在包装前对食品进行足够时间和充分温度的热处理，以使天然形成的酶部分地或完全失活，并使该食品产生物理或生化方面的变化。
5．关键控制点：是指食品加工过程中的一个点，在这个点上控制不当时，就可能造成或导致危害，或使成品受到杂质污染，或造成成品的腐败。
6．食品：指条例201（F）节所定义的食品．包括各种原料和辅料。
7．食品接触面：指与人类食品的接触表面以及在正常加工过程中因污水滴溅污染的并与食品接触的设备和工器具表面。
“食品接触面”包括与食品接触的工器具及设备的表面。
8．批：指在某一段时间生产的由具体代号标记的食品。
9．微生物：是指酵母菌、霉菌、细菌和病毒,包括（但不仅限于）对公众健康有影响的微生物种类。
“有害微生物”这个术语包括对公众健康有影响的，或使食品发酵分解的，或使食品受到杂质污染的、或使食品成为条例所指的劣质食品的微生物。
有时，美国食品与药物管理局在这些法规中使用“微生物”这个词，而不使用包含“微生物”一词的短语。
10．害虫：指令人厌恶的任何动物或昆虫，包括，但不仅限于鸟、啮齿动物、蝇和幼虫。
11．厂房：指用于人类食品加工、包装、标识或存放，或与人类食品的加工、包装、标识或存放有关的建筑物或设施或其中的某些部分。
12．质量控制操作：是指一种有计划的系统操作，并采取一切必要的行动防止食品成为条例所指的劣质食品。
13．返工品：是指由于一些不卫生因素而从加工过程中检选出的、干净的、未被掺杂的食品，或经过重新加工而再次调制，并适于消费的食品。
欧版GMPC-中文版手工翻译
优质化妆产品生产指导（GMPC）保护消费者健康目录介绍1.术语2.质量体系2.1介绍2.2员工2.3建筑2.4设备2.5程序及流程2.5.1程序和指引2.5.2流程3.采购3.1介绍3.2合同要求3.3采购文件4.生产4.1介绍4.2进场产品接收4.2.1原材，包装材料，散装产品4.2.2水4.2.3仓储4.3生产过程4.3.1准备4.3.2实际生产过程4.3.3待包装产品储存4.4包装4.5成品储存5.转包生产6.质量管理6.1介绍6.2质量控制6.2.1介绍6.2.2设备和试剂6.2.3控制活动6.2.4控制记录6.2.5留样和样品库6.3监控和数据使用6.4文件控制6.4.1跟踪文件6.4.2文件管理6.5不一致产品管理6.6卫生6.6.1工厂卫生6.6.2个人卫生6.7审核参考文献一、专业术语批次：被一个或多个操作所采用的某一原材料，包装材料或产品的指定的量。
他们被认为是一致的。
在线上生产的情况中，一个批次可以是在一段给定时间内一个产品的量。
二、质量体系2.1 介绍对于想达成其质量目标的企业，它应设计，应用和维护适应生产活动，产品特性和由公司高层支持的文件质量体系。
在生产层面，这个体系包括组织结构，职责和涉及质量管理的可用的资源，程序和流程。
组织结构应清晰设定以搞清楚企业的组织和运作。
它应包括企业规模和产品多样化程度。
企业应当在员工，场所，机器，设备和管理上有着合适和充足的资源。
质量体系要求对违规的分析，整改措施的落实，以及确保改进和足够的监管。
2.2 员工组织结构应是的在不同活动领域中有足够的员工层级：员工应具有技术，经验，适应他们呢职责和工作的能力和积极性。
为了这个目的，所有组织内各阶层员工的培训需求应当被识别并制定相应的培训计划。
员工应当：●知道他们在组织结构中的位置●知道他们的职责和任务●能接触到跟他们负责的生产环节相关的指引，信息和数据●持续被鼓励报告可能在各个生产环节出现的违规和其他不一致情况●遵守个人卫生要求，遵守有关工作和操作方法的指引能找到员工可以替代空缺很理想应采取所有必要措施来提高所有员工的技术和积极性：●培训：企业应建立和完成适合涉及执行不同生产操作（称重，执行，维护，行业卫生，生产过程中验证等）的任务和职责的培训活动。
ICH Q a原料药的GM 指南 中英对照
Q7a（中英文对照）FDA原料药GMP指南TableofContents 目录1.INTRODUCTION 1.简介1.1Objective 1.1目的1.2RegulatoryApplicability 1.2法规的适用性1.3Scope 1.3范围2.QUALITYMANAGEMENT 2.质量管理2.1Principles 2.1总则2.2质量部门的责任2.2ResponsibilitiesoftheQualityUnit(s)2.3生产作业的职责2.3ResponsibilityforProductionActivities2.4InternalAudits(SelfInspection) 2.4内部审计（自检）2.5ProductQualityReview 2.5产品质量审核3.PERSONNEL 3.人员3.1PersonnelQualifications 3.人员的资质3.2PersonnelHygiene 3.2人员卫生3.3Consultants 3.3顾问4.BUILDINGSANDFACILITIES 4.建筑和设施4.1DesignandConstruction 4.1设计和结构4.2Utilities 4.2公用设施4.3Water 4.3水4.4Containment 4.4限制4.5Lighting 4.5照明4.6SewageandRefuse 4.6排污和垃圾4.7SanitationandMaintenance 4.7卫生和保养5.PROCESSEQUIPMENT 5.工艺设备5.1DesignandConstruction 5.1设计和结构5.2EquipmentMaintenanceandCleaning 5.2设备保养和清洁5.3Calibration 5.3校验5.4ComputerizedSystems 5.4计算机控制系统6.DOCUMENTATIONANDRECORDS 6.文件和记录6.1DocumentationSystemandSpecificatio6.1文件系统和质量标准ns6.2EquipmentcleaningandUseRecord 6.2设备的清洁和使用记录6.3RecordsofRawMaterials,Intermediate s,APILabelingandPackagingMaterials 6.3原料、中间体、原料药的标签和包装材料的记录6.4MasterProductionInstructions(MasterProductionandControlRecords)6.4生产工艺规程（主生产和控制记录）6.5BatchProductionRecords(BatchProductionandControlRecords)6.5批生产记录（批生产和控制记录）6.6LaboratoryControlRecords 6.6实验室控制记录6.7BatchProductionRecordReview 6.7批生产记录审核7.MATERIALSMANAGEMENT7.物料管理7.1GeneralControls7.1控制通则7.2ReceiptandQuarantine7.2接收和待验7.3SamplingandTestingofIncomingProduc7.3进厂物料的取样与测试tionMaterials7.4Storage7.4储存7.5Re-evaluation7.5复验8.PRODUCTIONANDIN-PROCESSCONTROLS8.生产和过程控制8.1ProductionOperations8.1生产操作8.2TimeLimits8.2时限8.3 In-processSamplingandControls8.3工序取样和控制8.4BlendingBatchesofIntermediatesorAP8.4中间体或原料药的混批Is8.5ContaminationControl8.5污染控制9.PACKAGINGANDIDENTIFICATIONLABELINGO9.原料药和中间体的包装和贴签FAPIsANDINTERMEDIATES9.1General9.1总则9.2PackagingMaterials9.2包装材料9.3LabelIssuanceandControl9.3标签发放与控制9.4PackagingandLabelingOperations9.4包装和贴签操作10.STORAGEANDDISTRIBUTION10.储存和分发10.1WarehousingProcedures10.1入库程序10.2DistributionProcedures10.2分发程序BORATORYCONTROLS11.实验室控制11.1GeneralControls11.1控制通则11.2TestingofIntermediatesandAPIs11.2中间体和原料药的测试11.3ValidationofAnalyticalProcedures11.3分析方法的验证11.4CertificatesofAnalysis11.4分析报告单11.5StabilityMonitoringofAPIs11.5原料药的稳定性监测11.6ExpiryandRetestDating11.6有效期和复验期11.7Reserve/RetentionSamples11.7留样12.VALIDATION12.验证12.1ValidationPolicy12.1验证方针12.2ValidationDocumentation12.2验证文件12.3Qualification12.3确认12.4ApproachestoProcessValidation12.4工艺验证的方法12.5ProcessValidationProgram12.5工艺验证的程序12.6PeriodicReviewofValidatedSystems12.6验证系统的定期审核12.7CleaningValidation12.7清洗验证12.8ValidationofAnalyticalMethods12.8分析方法的验证13.CHANGECONTROL13.变更的控制14.REJECTIONANDRE-USEOFMATERIALS14.拒收和物料的再利用14.1Rejection14.1拒收14.2Reprocessing14.2返工14.3Reworking14.3重新加工14.4RecoveryofMaterialsandSolvents14.4物料与溶剂的回收14.5Returns14.5退货PLAINTSANDRECALLS15.投诉与召回16.CONTRACTMANUFACTURERS(INCLUDINGLABORATORIES)16.协议生产商（包括实验室）17.AGENTS,BROKERS,TRADERS,DISTRIBUTOR S,REPACKERS,ANDRELABELLERS 17.代理商、经纪人、贸易商、经销商、重新包装者和重新贴签者17.1Applicability17.1适用性17.2TraceabilityofDistributedAPIsandIntermediates17.2已分发的原料药和中间体的可追溯性17.3QualityManagement17.3质量管理17.4Repackaging,Relabeling,andHolding ofAPIsandIntermediates 17.4原料药和中间体的重新包装、重新贴签和待检17.5Stability17.5稳定性17.6TransferofInformation17.6信息的传达17.7HandlingofComplaintsandRecalls17.7投诉和召回的处理17.8HandlingofReturns17.8退货的处理18.SpecificGuidanceforAPIsManufacture dbyCellCulture/Fermentation 18.用细胞繁殖/发酵生产的原料药的特殊指南18.1General18.1总则18.2CellBankMaintenanceandRecordKeeping18.2细胞库的维护和记录的保存18.3CellCulture/Fermentation18.3细胞繁殖/发酵18.4Harvesting,IsolationandPurification18.4收取、分离和精制18.5ViralRemoval/Inactivationsteps18.5病毒的去除/灭活步骤19.APIsforUseinClinicalTrials19.用于临床研究的原料药19.1General19.1总则19.2Quality19.2质量19.3EquipmentandFacilities19.3设备和设施19.4ControlofRawMaterials19.4原料的控制19.5Production19.5生产19.6Validation19.6验证19.7Changes19.7变更19.8LaboratoryControls19.8实验室控制19.9Documentation19.9文件20.Glossary20.术语Q7aGMPGuidanceforAPIsQ7a原料药的GMP指南1.INTRODUCTION 1.简介1.1Objective 1.1目的Thisdocumentisintendedtoprovideguidan ceregardinggoodmanufacturingpractice( GMP)forthemanufacturingofactivepharma ceuticalingredients(APIs)underanappro priatesystemformanagingquality.Itisal sointendedtohelpensurethatAPIsmeetthe qualityandpuritycharacteristicsthatth eypurport,orarerepresented,topossess.本文件旨在为在合适的质量管理体系下制造活性药用成分（以下称原料药）提供有关优良药品生产管理规范（GMP）提供指南。
阿司匹林片(片剂)工艺规程完整
阿司匹林片工艺规程1.产品名称及剂型1.1产品名称：阿司匹林片1.2产品剂型：片剂2.产品概述2.1产品名称阿司匹林片汉语拼音名：Asipilin Pian英文名：Aspirin Tablets结构式：阿司匹林本品为２－（乙酰氧基）苯甲酸分子式：C9H8O4 分子量：180.16本品含阿司匹林（C9H8O4）应为标示量的95.0%-105.0%2.2产品特点2.2.1性状本品为白色片2.2.2规格0.5g。
2.2.3类别解热镇痛非甾体抗炎药，抗血小板聚集药。
2.2.4用法与用量口服。
成人一次1片，若发热或疼痛持续不缓解，可间隔4-一6个小时重复用药一次。
24小时不超过4片。
儿童用量请咨询医师或药师。
2.2.5贮藏密封，在干燥处保存。
2.2.6有效期3年。
3.处方和依据3.1批投料处方阿司匹林60kg淀粉5kg枸橼酸0.6kg滑石粉 1.25kg制成12万片3.2依据执行标准：《中国药典》2010年版二部3.3制法 取阿司匹林、淀粉和枸橼酸置高效湿法制粒机中混合均匀，用淀粉浆制粒；干燥；压片；瓶包装及外包装，制得。
4. 工艺流程图物料工序检验入库中间站注：虚线框为十万级洁净区。
5.操作过程及工艺条件 5.1备料5.1.1领料从库房领取合格原辅料，送入车间称量暂存间。
5.1.2粉碎过筛将以下物料依次粉碎过筛，过筛后再次称量，计算物料平衡，并严格复核。
5.2制粒5.2.1配浆称取纯化水1kg置配浆锅中，加入1kg淀粉，搅拌使均匀，在搅拌下冲入10kg 纯化水加热至糊化，配成10%的淀粉浆作为粘合剂。
5.2.2制粒将60kg阿司匹林粉、4kg淀粉和0.6kg枸橼酸粉投入高速制粒机中，干混4分钟后，加入上述淀粉浆混合5分钟，开机制粒。
5.2.3干燥将上述湿颗粒吸入沸腾制粒机中，将设定好工艺参数（进风温度120±5℃，温度75±5℃，进风温度30±5℃）的冷空气通过初效中高效过滤器进适入后部加热室，经过加热器加热至进风所需温度后进入物料室，在引风拉动下物料呈流化态干燥45分钟至水份为3-4%时，停机出料。